Literature DB >> 13689863

Initial clinical studies with 5-iodo-2'-deoxyuridine.

P CALABRESI, S S CARDOSO, S C FINCH, M M KLIGERMAN, C F VON ESSEN, M Y CHU, A D WELCH.   

Abstract

Entities:  

Keywords:  NEOPLASMS/therapy; NUCLEOSIDES AND NUCLEOTIDES/therapy

Mesh：

Substances：

Year:  1961        PMID： 13689863

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  Regional protection in cancer chemotherapy. 1. Infusions of thymidine into external carotid artery of patients receiving systemic 5-iodo-2'-deoxyuruidine.

Authors:  P CALABRESI
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

Review 2.  Antiviral chemotherapy: the first decade.

Authors:  D J Bauer
Journal:  Br Med J       Date:  1973-08-04

3.  Herpes simplex encephalitis treated with intravenous idoxuridine.

Authors:  A D Evans; O P Gray; M H Miller; E R Jones; R D Weeks; C E Wells
Journal:  Br Med J       Date:  1967-05-13

Review 4.  Structure-activity relationships and conformational features of antiherpetic pyrimidine and purine nucleoside analogues. A review.

Authors:  T Kulikowski
Journal:  Pharm World Sci       Date:  1994-04-15

5.  First-in-human phase 0 trial of oral 5-iodo-2-pyrimidinone-2'-deoxyribose in patients with advanced malignancies.

Authors:  Shivaani Kummar; Larry Anderson; Kimberly Hill; Eva Majerova; Deborah Allen; Yvonne Horneffer; S Percy Ivy; Larry Rubinstein; Pamela Harris; James H Doroshow; Jerry M Collins
Journal:  Clin Cancer Res       Date:  2013-02-12       Impact factor: 12.531

6.  Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis.

Authors:  A M Lerner; E J Bailey
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

7.  Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients.

Authors:  A W Chow; A Roland; M Fiala; W Hryniuk; M L Weil; J S Geme; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

Review 8.  Antiviral therapy.

Authors:  H Stalder
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct

9.  The influence of high dose hydroxyurea on the incorporation of 5-iodo-2-deoxyuridine (IUdR) by human bone marrow and tumour cells in vivo.

Authors:  P A Philip; L Kaklamanis; J Carmichael; K Tonkin; H Morrison; K Gatter; A L Harris
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.